跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADYNOVATE - SFDA Drug Approval Details
Approvals
/
SFDA
/
ADYNOVATE
Authorized
BIOLOGICAL
ADYNOVATE
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
09951e8d654ff1d7
Company
Unknown
Type
Biological
Approval Details
Approval Id
09951e8d654ff1d7
Drug Approval Sfda Name
ADYNOVATE
Trade Name
ADYNOVATE
Generic Name
ANTIHEMOPHILIC FACTOR, PEGYLATED (MW 20000) HUMAN SEQUENCE RECOMBINANT
Register Number
6-5888-25
Register Year
2020
Drug Type
Biological
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Size
5
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
Store in a refrigerator (2°C – 8°C), do not freeze
Shelf Life
24 Months
Distribution Site
Hospital
Description Code
8000000804-1000-100000073868
Price
1688.89
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
09951e8d654ff1d7
Type
Biological
Back to SFDA Approvals